Anavex Life Sciences (AVXL) Earnings Date & Reports

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVXL is expected to report earnings to rise 15.43% to -8 cents per share on August 11

Anavex Life Sciences AVXL Stock Earnings Reports

Q2'26

Est.

$-0.08

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.06

Q3'25

Beat

by $0.03

Q2'25

Missed

by $0.01

The last earnings report on May 07 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 434.86K shares outstanding, the current market capitalization sits at 276.16M.

View a ticker or compare two or three

Compare

AVXL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AVXL